Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of AST-120 (Kremezin) in Patients With Moderate to Severe CKD

PaperCitations, authors & open-access status

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of AST-120 (Kremezin) in Patients With Moderate to Severe CKD is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 198 citations, 2006 year and closed oa status.

198
Citations
2006
Year
closed
OA Status

Related on ScholarIQ

Samuel S. Blumenthal
Author
American Journal of Kidney Diseases
Journal
Dialysis and Renal Disease Management
Topic
Dialysis and Renal Disease Management
Topic
Coffee research and impacts
Topic
Chronic Kidney Disease and Diabetes
Topic
470M+ articles · free account